121 related articles for article (PubMed ID: 1691654)
21. Characterization of HIV replication complexes early after cell-to-cell infection.
Karageorgos L; Li P; Burrell C
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):817-23. PubMed ID: 7504934
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
Montaner LJ; Griffin P; Gordon S
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
[TBL] [Abstract][Full Text] [Related]
23. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679.
deSolms SJ; Giuliani EA; Guare JP; Vacca JP; Sanders WM; Graham SL; Wiggins JM; Darke PL; Sigal IS; Zugay JA
J Med Chem; 1991 Sep; 34(9):2852-7. PubMed ID: 1910089
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 infection of endothelial cells in vitro.
Re MC; Furlini G; Cenacchi G; Preda P; La Placa M
Microbiologica; 1991 Apr; 14(2):149-52. PubMed ID: 1713288
[TBL] [Abstract][Full Text] [Related]
26. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
Clark SJ; Saag MS; Decker WD; Campbell-Hill S; Roberson JL; Veldkamp PJ; Kappes JC; Hahn BH; Shaw GM
N Engl J Med; 1991 Apr; 324(14):954-60. PubMed ID: 1900576
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
Sundqvist VA; Albert J; Ohlsson E; Hinkula J; Fenyö EM; Wahren B
J Med Virol; 1989 Nov; 29(3):170-5. PubMed ID: 2482339
[TBL] [Abstract][Full Text] [Related]
28. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease.
Schnittman SM; Greenhouse JJ; Lane HC; Pierce PF; Fauci AS
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):361-7. PubMed ID: 1676896
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
30. Infection of human thymic lymphocytes by HIV-1.
Tremblay M; Numazaki K; Goldman H; Wainberg MA
J Acquir Immune Defic Syndr (1988); 1990; 3(4):356-60. PubMed ID: 1690286
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of HIV-1 marker detection in cell cultures treated with mild heat-shock.
Furlini G; Re MC; Musiani M; Zerbini ML; La Placa M
Microbiologica; 1990 Jan; 13(1):21-6. PubMed ID: 1689802
[TBL] [Abstract][Full Text] [Related]
32. Sodium pentosan polysulfate (PPS), an anti-HIV agent also exhibits synergism with AZT, lymphoproliferative activity, and virus enhancement.
Anand R; Nayyar S; Galvin TA; Merril CR; Bigelow LB
AIDS Res Hum Retroviruses; 1990 May; 6(5):679-89. PubMed ID: 1694454
[TBL] [Abstract][Full Text] [Related]
33. Oxophenarsine, an antisyphilis drug inhibits HIV-1-specific protein synthesis in acutely and persistently infected lymphocytes.
Gupta P; Balachandran R; Thampatty P; Rinaldo C; Ho M
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1417-23. PubMed ID: 2078419
[TBL] [Abstract][Full Text] [Related]
34. CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor.
Brinchmann JE; Gaudernack G; Vartdal F
J Immunol; 1990 Apr; 144(8):2961-6. PubMed ID: 1969879
[TBL] [Abstract][Full Text] [Related]
35. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus.
Schinazi RF; Chu CK; Babu JR; Oswald BJ; Saalmann V; Cannon DL; Eriksson BF; Nasr M
Antiviral Res; 1990 May; 13(5):265-72. PubMed ID: 1697740
[TBL] [Abstract][Full Text] [Related]
36. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.
Fernie BF; Poli G; Fauci AS
J Virol; 1991 Jul; 65(7):3968-71. PubMed ID: 1710293
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives.
Mihm S; Ennen J; Pessara U; Kurth R; Dröge W
AIDS; 1991 May; 5(5):497-503. PubMed ID: 1907460
[TBL] [Abstract][Full Text] [Related]
39. Surrogate markers for AIDS treatment.
Jacobson M
Nurs Times; 1991 May 29-Jun 4; 87(22):49. PubMed ID: 1675013
[No Abstract] [Full Text] [Related]
40. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.
Sperber K; Kalb TH; Stecher VJ; Banerjee R; Mayer L
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):91-8. PubMed ID: 8427717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
